Related Experiment Video

Updated: Dec 5, 2025

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

11.5K

Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins

Adriana Gutiérrez-Hoya1,2, Isabel Soto-Cruz1

  • 1Molecular Oncology Laboratory, Cell Differentiation and Cancer Research Unit, FES Zaragoza, National University of Mexico, Batalla 5 de Mayo s/n Col. Ejército de Oriente, Mexico 09230, Mexico.

Cells
|October 20, 2020
PubMed

Insights

The janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in cervical cancer. Inhibiting JAK/STAT signaling may enhance tumor cell death and improve patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Virology

Background:

  • The janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway regulates vital cellular processes like proliferation, survival, and immunity.
  • Aberrant JAK/STAT signaling is implicated in cancer progression, particularly cervical cancer, where STAT protein overactivation correlates with poor prognosis.
  • Human papillomavirus (HPV) oncoproteins E6 and E7 are critical in cervical cancer development and may activate the JAK/STAT pathway.

Purpose of the Study:

  • To review the role of JAK/STAT pathway components in cervical cancer.
  • To explore the link between HPV and JAK/STAT pathway activation in cellular malignancy.
  • To highlight the therapeutic potential of inhibiting the JAK/STAT pathway in cervical cancer treatment.

Main Methods:

  • Literature review of studies on JAK/STAT signaling in cancer.
  • Analysis of the role of STAT proteins in cervical cancer development.
  • Investigation of the interaction between HPV oncoproteins and the JAK/STAT pathway.

Main Results:

  • STAT proteins are essential in cervical cancer progression, and their persistent activation is linked to poor survival.
  • The JAK/STAT pathway is a potential therapeutic target for enhancing cervical cancer cell death.
  • HPV oncoproteins E6 and E7 may mediate JAK/STAT pathway activation.

Conclusions:

  • Inhibition of the JAK/STAT pathway shows promise as a novel therapeutic strategy for cervical cancer.
  • Targeting STAT proteins could be crucial for improving treatment outcomes in cervical cancer.
  • Understanding the interplay between HPV and JAK/STAT signaling is vital for advancing cervical cancer therapy.
Keywords:
HPVSTAT inhibitorscervical cancersignal transducer and activator of transcriptionsignaling pathway

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.8K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.9K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.5K